Public

Hillgene Biopharma Co., Ltd

by hillgene

Entries 4

Page 1 of 1

Cell Cytotoxicity is a critical quality attribute (CQA) for the biological activity of immune cell therapy products (e.g., NK cells, CAR-NK cells, Tm cells, CAR-T or TCR-T cells, etc.), and it i...


CD19 CAR T cell preparation kit is composed of three parts: T cell activation and expansion unit, T cell purification unit and CD19 CAR gene transduction unit. The T cell activation and expansio...


This Bovine Serum Albumin ELISA Kit is designed for the quantitative detection of residual BSA content in intermediates, semifinished products, and finished products of various biological produc...


BlueKit for mRNA is a specialized assay solution featuring elispot elisa kits for DNase I, RNase inhibitors, T7 RNA polymerase, dsRNA, inorganic pyrophosphatase, and Vaccinia capping enzyme. Ide...


Book Description

A dedicated solution provider of cellular therapy products.have built an express pathway for the development of cellular therapy products from discovery to delivery, by establishing cellular therapy product specific platforms for nucleic acid manufacturing, serum-free suspension culturing, completely closed process development for cellular therapy products, and QC testing technology. Our platforms have supported lots of partners in the successful development of several CAR-T, TCR-T, and stem cell-based products. Hillgene is committed to bringing more products to the next milestone sooner and faster, facilitating the marketing of more cellular therapy products, thereby benefiting more patients, and writing a whole new chapter of life for cellular therapy products.